Elevance Health reaffirms FY 2026 earnings guidance of at least $20.10
The company says it expects FY 2026 adjusted earnings per diluted share of at least $27.
Story updates
10:12:58 AM UTC
SquawkNews
ELV ELEVANCE HEALTH: REAFFIRMS FY 2026 EARNINGS GUIDANCE OF AT LEAST $20.10 PER DILUTED SHARE - SEC FILING
10:13:24 AM UTC
SquawkNews
Elevance Health reaffirmed full-year 2026 shareholders' earnings guidance of at least $20.10 per diluted share, including about $6.90 of net unfavorable items.Key Highlights:Original SEC Filing: Elevance Health, Inc. [ ELV ] - 8-K - Sep. 10, 2026This is an AI-powered summary. It may contain inaccur…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.